Legislation

This ordinance requires medical specimen collection sites to partner with a government entity, licensed healthcare provider, or educational institution, and to follow hygiene, sanitation, and privacy standards. Violations of these standards can result in administrative penalties from the Department of Public Health.

Ordinance amending the Health Code to require that sites that collect medical specimens on behalf of clinical laboratories partner with either a governmental entity, a licensed health care provider located in the City, or an educational or academic institution, establish hygiene, sanitation, and privacy standards, and adhere to the Health Insurance Portability and Accountability Act; and providing that a violation of the specimen collection standards is a public health nuisance subject to an administrative penalty that may be imposed by the Department of Public Health.

The hearing aims to evaluate the city's approach to criminalizing individuals with substance use disorders, including data on arrests and their effects on health and services. It requests reports from various city departments to assess compliance with state laws regarding harm reduction materials.

Hearing to discuss the increased efforts to criminalize individuals suffering from substance use disorder; and to provide data on how many individuals have been arrested, the results of those arrests, the impact of this effort on the health of drug users, the impact of this effort on service providers and use of harm reduction services, and how the police are complying with state laws that protect harm reduction materials from confiscation by police; and requesting the Mayor's Office, Police Department, Office of the District Attorney, Department of Emergency Management, Sheriff's Department, Office of the Public Defender, Department of Homelessness and Supportive Housing, and Department of Public Health to report.

This legislation aims to address open-air drug dealing in San Francisco by prioritizing investigations, arrests, and prosecutions related to these activities, while also focusing on reducing the supply of opioids. It requests reports from the Police Command Staff and the District Attorney on their strategies and actions.

Hearing to consider the City's comprehensive strategy to prioritize the investigation, arrests, charging and prosecution of San Francisco's rampant open-air street-level drug dealing rings, as well as cutting off the supply of deadly opioids; and requesting the Police Command Staff and the District Attorney to report.

This legislation calls for a hearing to review the Department of Public Health's Behavioral Health Services case management system, focusing on the number of case managers, their locations, client interaction frequency, caseloads, and vacant positions. The Department of Public Health is required to provide a report on these aspects.

Hearing on Department of Public Health's Behavioral Health Services case management system; specifically examining how many behavioral health and substance use case managers are in the system, their work location, the process for providing case management at varying levels of need, frequency of case managers interacting with their clients, the caseload of case managers at every level of care, and the number of funded but vacant case manager positions exist in the entire system of care; and requesting Department of Public Health's Behavioral Health Services to report.

This ordinance approves the health insurance plans and the contribution rates for the Health Service System for the year 2024. It ensures that city employees have access to health benefits and outlines how much they will contribute to those plans.

Ordinance approving Health Service System plans and contribution rates for calendar year 2024.

This ordinance allows the Department of Public Health to approve managed care contracts until December 31, 2028, without needing a review from the Controller for certain contracts based on state-set rates or actual healthcare costs. It amends the Administrative Code to extend this authority from the Board of Supervisors.

Ordinance amending the Administrative Code to extend the Board of Supervisors’ delegation of authority under Charter, Section 9.118, to the Department of Public Health to approve managed care contracts to include contracts ending on December 31, 2028; and to exclude from the requirement of Controller review those managed care contracts that are based on rates set by the California Department Health Care Services or on actual healthcare delivery costs.

This ordinance updates the fees for emergency medical services to align with annual adjustments and introduces fees for additional services. It also defines "trauma center" and "pediatric center" in the Health Code.

Ordinance amending the Business and Tax Regulations Code to update emergency medical services fees to reflect amounts authorized under annual adjustment provisions and to require fees for certain additional services; and amending the Health Code to define the terms “trauma center” and “pediatric center.”

This ordinance updates the Health Code to establish the fees that patients will pay and the costs for other services offered by the Department of Public Health for the fiscal years 2023-2024 and 2024-2025. It has been officially passed.

Ordinance amending the Health Code to set patient rates and rates for other services provided by the Department of Public Health, for Fiscal Years 2023-2024 and 2024-2025.

This resolution allows the Office of Cannabis to accept and use a $3 million grant from the Board of State and Community Corrections for public health and safety initiatives related to Proposition 64, covering the period from May 1, 2023, to October 31, 2028. It also authorizes the Office to manage the agreement and any future changes on behalf of the city.

Resolution retroactively authorizing the Office of Cannabis to accept and expend a grant award in the amount of $3,000,000 from the Board of State and Community Corrections for the Proposition 64 Public Health and Safety Grant Program for a term of May 1, 2023, through October 31, 2028; and authorizing the Office of Cannabis to execute the agreement with the Board of State and Community Corrections, and any extensions, amendments, or contracts subsequent thereto on behalf of the City and County of San Francisco.

This resolution allows the Department of Public Health to accept and use an additional $2,555,761 grant, bringing the total to $7,223,161, to support efforts in combating HIV and AIDS through a federal program. The funding will be utilized from March 1, 2020, to February 28, 2024.

Resolution retroactively authorizing the Department of Public Health to accept and expend a grant increase in the amount of $2,555,761 for a total amount of $7,223,161 from the Health Resources and Services Administration for participation in a program, entitled “Ending The Human Immunodeficiency Virus (HIV) Epidemic: A Plan for America - Ryan White Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS) Program Parts A and B,” for the period of March 1, 2020, through February 28, 2024.

The resolution allows certain city services, including security and food services, to be contracted out to private companies if they can perform the work at a lower cost than city employees. This includes services for various departments such as the Board of Supervisors, General Services Agency, and the Sheriff's Department.

Resolution concurring with the Controller's certification that department services previously approved can be performed by a private contractor for a lower cost than similar work performed by City and County employees, for the following services: Budget and Legislative Analyst Services (Board of Supervisors); Fleet Security Services, Real Estate Division Custodial Services, Real Estate Division Security Services, and Convention Facilities Management (General Services Agency - Administrative Services); Security Services (Department of Public Works); Security Services (Homelessness and Supportive Housing); Security Services (Human Services Agency); Food Services at County Jails (Sheriff’s Department); Assembly of Vote by Mail Services (Department of Elections); Security Services (Mayor’s Office of Housing and Community Development); and Security Services (Department of Public Health).

This resolution allows the San Francisco Department of Public Health to accept and spend state grant funds for the fiscal year 2023-2024. It ensures that the department has the financial resources needed to support public health initiatives during that period.

Resolution authorizing the acceptance and expenditure of State grant funds by the San Francisco Department of Public Health for Fiscal Year (FY) 2023-2024.

This resolution allows San Francisco's Department of Public Health to enter into agreements with the California Department of Health Care Services for reimbursement under the Medi-Cal County Inmate Program, totaling up to $24,443.73 from July 1, 2023, to June 30, 2026. It also makes the City responsible for any penalties or interest from federal audits related to these services.

Resolution retroactively authorizing the City and County of San Francisco (City), acting by and through its Department of Public Health (DPH), to enter into the following two related agreements with the California Department of Health Care Services (State) for reimbursement under the State’s Medi-Cal County Inmate Program (MCIP): 1) Participation Agreement 23-MCIPSANFRANCISCO-38; and 2) Administrative Services Agreement No. 23-30045; in the amount not to exceed $24,443.73 for a term period of July 1, 2023, through and including June 30, 2026, authorizing the City to assume sole financial responsibility for any and all penalties and interest charged as a result of a federal audit disallowance related to the rendering of services by the State under the MCIP; and authorizing DPH to enter into modifications to the agreements that do not materially increase the obligations or liabilities to the City and are necessary to effectuate the purposes of the Agreements or this Resolution.

The resolution supports Governor Gavin Newsom's proposal to modernize California's behavioral healthcare system, which includes updating the Mental Health Services Act and a $4.68 billion bond to create at least 10,000 new behavioral health beds. It has passed and aims to improve mental health services across the state.

Resolution supporting Governor Gavin Newsom’s 2024 ballot initiative proposal to modernize California’s behavioral healthcare system, which includes California State Senate Bill No. 326, an update of the Mental Health Services Act authored by Senator Susan Talamantes Eggman, and California State Assembly Bill No. 531, a bill authored by Jacqui Irwin that would place before the voters a $4.68 billion General Obligation Bond intended to build at least 10,000 new behavioral health beds across California community treatment campuses and facilities.

The ordinance authorizes the City and County of San Francisco to settle a lawsuit for $100,000 related to alleged medical negligence filed by Breon Johnson. This lawsuit was initiated on September 26, 2022, in San Francisco Superior Court.

Ordinance authorizing settlement of the lawsuit filed by Breon Johnson against the City and County of San Francisco for $100,000; the lawsuit was filed on September 26, 2022, in San Francisco Superior Court, Case No. CGC-22-601937; entitled Breon Johnson v. The Regents of The University of California, et al.; the lawsuit involves alleged medical negligence.

This resolution officially designates August 31, 2023, as International Overdose Awareness Day in San Francisco. It aims to raise awareness about overdose prevention and honor those affected by overdose.

Resolution recognizing August 31, 2023, as an International Overdose Awareness Day in the City and County of San Francisco.

This resolution approves an agreement between the San Francisco Public Health Foundation and the Department of Public Health to outline their roles in fundraising and capital projects. It also allows the Department of Public Health to make minor changes to the agreement before it is finalized, as long as those changes do not significantly increase the city's obligations.

Resolution approving the Memorandum of Understanding (MOU) between the San Francisco Public Health Foundation and the Department of Public Health to establish the roles and responsibilities of each party for purposes of fundraising and capital projects; and to authorize the Department of Public Health to enter into amendments or modifications to the MOU prior to its final execution by all parties that do not materially increase the obligations or liabilities to the City and are necessary to effectuate the purposes of the MOU or this Resolution.

This resolution approves an agreement between the San Francisco General Hospital Foundation and the City’s Department of Public Health to outline their roles in fundraising and capital projects. It also allows the Department to make minor changes to the agreement before it is finalized, as long as those changes do not significantly increase the City's obligations.

Resolution approving the Memorandum of Understanding (MOU) between the San Francisco General Hospital Foundation and the City and County of San Francisco, acting by and through its Department of Public Health, to establish the roles and responsibilities of each party for purposes of fundraising and capital projects; and to authorize the Department of Public Health to enter into amendments or modifications to the MOU prior to its final execution by all parties that do not materially increase the obligations or liabilities to the City and are necessary to effectuate the purposes of the MOU or this Resolution.

The ordinance authorizes a settlement of $229,610,002 from Walgreen Co. related to their improper dispensing of prescription opioids, which contributed to the opioid crisis in San Francisco. The City will receive $200,000,002 over 15 years, while outside counsel will be paid $29,610,000.

Ordinance authorizing settlement of the lawsuit filed by the City and County of San Francisco and the People of the State of California against Walgreen Co. for $229,610,002 (the City to be paid $200,000,002 over 15 years, the City’s outside counsel to be paid $29,610,000); the lawsuit was filed on December 18, 2018, in the United States District Court for the Northern District of California, Case No. 3:18-cv-7591-CRB-JSC; entitled The City and County of San Francisco and the People of the State of California v. Purdue Pharma L.P., Richard S. Sackler, Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A. Sackler, Ilene Sackler Lefcourt, Beverly Sackler, Theresa Sackler, David A. Sackler, Trust for the Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo International Plc, Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics, Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc f/k/a Actavis Plc, Watson Pharmaceuticals, Inc. n/k/a Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. f/k/a Watson Pharma, Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation; the lawsuit involves Walgreen Co.’s improper and unlawful dispensing of prescription opioids at its pharmacies, which contributed to the epidemic of opioid abuse and misuse and caused a public nuisance in San Francisco.

The ordinance authorizes a settlement of nearly $25 million from several pharmaceutical companies for their role in misleadingly marketing opioids and contributing to the opioid crisis in San Francisco. It allocates funds for the City Attorney's Office and includes naloxone valued at $20 million to help combat opioid overdoses.

Ordinance authorizing settlement of the lawsuit filed by the City and County of San Francisco and the People of the State of California against Cephalon, Inc.; Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries Ltd; Watson Laboratories, Inc.; Actavis LLC; Actavis Pharma, Inc. (f/k/a Watson Pharma, Inc.); Actavis Elizabeth LLC; Actavis Mid Atlantic LLC; Warner Chilcott Company, LLC; Actavis South Atlantic LLC; Actavis Totowa LLC; Actavis Kadian LLC; Actavis Laboratories UT, Inc. (f/k/a/ Watson Laboratories, Inc.-Salt Lake City); Actavis Laboratories FL, Inc. (f/k/a Watson Laboratories, Inc.-Florida); and Anda, Inc. for $24,797,604 (the City to be paid $19,499,928 over 13 years, the City’s outside counsel to be paid $3,043,340, and the City Attorney’s Office to be paid $2,254,336) and naloxone valued at $20,000,000; directing the Controller to allocate funds to the City Attorney’s Office as provided in the settlement agreement; the lawsuit was filed on December 18, 2018, in the United States District Court for the Northern District of California, Case No. 3:18-cv-7591-CRB-JSC; entitled The City and County of San Francisco and the People of the State of California v. Purdue Pharma L.P., Richard S. Sackler, Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A. Sackler, Ilene Sackler Lefcourt, Beverly Sackler, Theresa Sackler, David A. Sackler, Trust for the Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo International Plc, Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics, Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc f/k/a Actavis Plc, Watson Pharmaceuticals, Inc. n/k/a Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. f/k/a Watson Pharma, Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation; the lawsuit involves allegations that the Teva defendants created a public nuisance and violated the Unfair Competition Law by falsely and misleadingly marketing opioids as safer than they actually are and distributing increasingly large volumes of opioids in and around San Francisco despite knowledge of the growing epidemic caused by opioid misuse, and by failing to prevent and report suspicious opioid orders as required by state and federal law.

The ordinance authorizes a settlement of nearly $12.9 million from Allergan related to a lawsuit over misleading opioid marketing and distribution practices that contributed to the opioid crisis in San Francisco. The settlement allocates funds for the City, outside counsel, and the City Attorney's Office over a five-year period.

Ordinance authorizing settlement of the lawsuit filed by the City and County of San Francisco and the People of the State of California against Allergan Finance, LLC (f/k/a Actavis, Inc., which, in turn, was f/k/a Watson Pharmaceuticals, Inc.) and Allergan Limited (f/k/a Allergan plc, which, in turn, was f/k/a Actavis plc) for $12,916,274 (the City to be paid $10,156,889 over 5 years, the City’s outside counsel to be paid $1,585,179, and the City Attorney’s Office to be paid $1,174,206); directing the Controller to allocate funds to the City Attorney’s Office as provided in the settlement agreement; the lawsuit was filed on December 18, 2018, in the United States District Court for the Northern District of California, Case No. 3:18-cv-7591-CRB-JSC; entitled The City and County of San Francisco and the People of the State of California v. Purdue Pharma L.P., Richard S. Sackler, Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A. Sackler, Ilene Sackler Lefcourt, Beverly Sackler, Theresa Sackler, David A. Sackler, Trust for the Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo International Plc, Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics, Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc f/k/a Actavis Plc, Watson Pharmaceuticals, Inc. n/k/a Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. f/k/a Watson Pharma, Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation; the lawsuit involves allegations that the Allergan defendants created a public nuisance and violated the Unfair Competition Law by falsely and misleadingly marketing opioids as safer than they actually are and distributing increasingly large volumes of opioids in and around San Francisco despite knowledge of the growing epidemic caused by opioid misuse, and by failing to prevent and report suspicious opioid orders as required by state and federal law.

This resolution retroactively approves a funding agreement between the San Francisco Department of Public Health and Advocates for Human Potential, Inc., which is expected to bring in nearly $2 million to the city from September 2021 to June 2025. It also allows the Department of Public Health to make minor changes to the agreement without increasing the city's obligations.

Resolution retroactively approving an agreement, for a term of September 15, 2021, through June 30, 2025, between the San Francisco Department of Public Health and Advocates for Human Potential, Inc. having anticipated revenue to the City of $1,977,500; and to authorize the Department of Public Health to enter into amendments or modifications to the agreement prior to its final execution by all parties that do not materially increase the obligations or liabilities to the City and are necessary to effectuate the purposes of the agreement or this Resolution.

This resolution outlines the overdose prevention strategies that various San Francisco departments and their partners will implement to reduce drug overdoses among clients who use drugs. It is a formal acknowledgment of their plans, as required by city regulations.

Resolution receiving Overdose Prevention Policies for the Department of Public Health, Department of Homelessness and Supportive Housing, Healthy Streets Operation Center through the Department of Emergency Management, and the Human Services Agency describing how the department and its grantees that provide direct services to clients who use drugs will promote strategies to reduce drug overdoses, submitted as required by Administrative Code, Section 15.17.

This hearing aims to evaluate the current state of sub-acute care in San Francisco and discuss strategies to improve care for vulnerable individuals to reduce preventable deaths. The Department of Public Health will be asked to provide a report on this issue.

Hearing to discuss the status of sub-acute care in San Francisco and plans to care for this vulnerable population to prevent unnecessary deaths; and requesting the Department of Public Health to report.

This hearing reviews the city's response to motor vehicle stunt driving and updates on an ordinance aimed at enforcing laws against reckless driving and speed contests. It also requests reports from the Municipal Transportation Agency, Police Department, and Public Works on these issues.

Hearing to review the response to Motor Vehicle Stunt Driving and receive updates on the Ordinance amending the Police and Transportation Codes to establish a City policy to protect the health and safety of residents by enforcing state laws prohibiting reckless driving, motor vehicle speed contests, and exhibitions involving stunt and tricks with vehicles; and requesting the Municipal Transportation Agency, Police Department, and Public Works to report.

The ordinance authorizes a payment of $211,129.46 to Build Group, Inc. to settle a lawsuit regarding a breach of contract related to the renovation of the Maxine Hall Health Center, with Build Group waiving any further claims related to the project. This settlement resolves a cross-complaint filed against the City in November 2022.

Ordinance authorizing settlement of the cross-complaint filed by Build Group, Inc. against the City and County of San Francisco for a payment to Build Group, Inc. of $211,129.46; the cross-complaint was filed on November 22, 2022, in the Superior Court of the State of California, County of San Francisco, Case No. CGC-22-598717; entitled CPM Environmental, Inc. v. Build Group, Inc. and DOES 1-100, et al.; the lawsuit involves allegations of breach of contract relating to the renovation of the Maxine Hall Health Center; other material terms of the settlement are that Build Group, Inc. waives all other claims it has or may have relating to the project.

This resolution approves an emergency declaration for repair work at Laguna Honda Hospital, allowing the city to spend up to $28.4 million for necessary repairs. The work is deemed urgent and exceeds the typical spending limit for such projects.

Resolution approving the Director of Public Works’ declaration of emergency under Administrative Code, Section 6.60, for repair work at Laguna Honda Hospital and Rehabilitation Center, located at 375 Laguna Honda Boulevard, estimated to cost in excess of $250,000 but not to exceed $28,400,000.

This resolution allows the Police Department to accept and use 900 units of Naloxone, a medication that can reverse opioid overdoses, valued at $48,750. The Naloxone is provided through a project funded by a federal health agency and managed by the Department of Health Care Services.

Resolution retroactively authorizing the Police Department to accept and expend an in-kind gift of 900 units of Naloxone valued at $48,750 through the Naloxone Distribution Project, which is funded by the Substance Abuse and Mental Health Services Administration and administered by the Department of Health Care Services.

This resolution urges the San Francisco Department of Public Health to develop a program that offers resources and education to gun violence victims about their legal rights to sue gun manufacturers under California Assembly Bill No. 1594. It has been passed by the city legislature.

Resolution urging the San Francisco Department of Public Health to create a program to provide resources and education for victims of gun violence regarding their rights to file lawsuits against gun manufacturers in accordance to California State Assembly Bill No. 1594.

The ordinance authorizes a settlement of $2,223,500 for a lawsuit against the City and County of San Francisco related to allegations of abuse and privacy violations at Laguna Honda Hospital. This settlement is subject to approval by the Probate Court.

Ordinance authorizing settlement of the lawsuit, subject to the approval of the Probate Court, filed by Jane Doe 1, Jane Doe 4, Jane Doe 5, Jane Doe 6, Jane Doe 9, John Doe 1, John Doe 2, John Doe 3, John Doe 4, John Doe 6, John Doe 7 against the City and County of San Francisco for $2,223,500; the lawsuit was filed on May 28, 2021, in San Francisco Superior Court, Case No. CGC-21-592296; entitled Jane Doe 1, et al. v. City and County of San Francisco, et al.; the lawsuit involves allegations of abuse and privacy violations brought by current and former residents of Laguna Honda Hospital and Rehabilitation Center.

This resolution supports a California state bill that aims to expand health insurance to cover infertility treatments and fertility services. It has been passed by the San Francisco city government.

Resolution supporting California State Senate Bill No. 729, authored by State Senator Caroline Menjivar, to expand health insurance coverage to include treatments for infertility and fertility services.

This ordinance allocates $5.5 million from the city's reserve funds to the Department of Public Health to establish wellness hubs aimed at providing drug and alcohol treatment services. The funding is designated for the fiscal year 2022-2023.

Ordinance appropriating $5,500,000 of General Fund General Reserves to the Department of Public Health for wellness hubs for the purpose of providing drug and alcohol treatment to members of the public in Fiscal Year (FY) 2022-2023.

This resolution states that the Board of Supervisors plans to use some of the funds from the city's opioid litigation to create wellness hubs as part of the Department of Public Health's Overdose Prevention Plan by 2025. It is currently filed and has not yet been enacted.

Resolution declaring the Board of Supervisors’ intent to use a portion of the abatement funds arising from San Francisco’s opioid litigation to open and operate wellness hubs, as outlined by the Department of Public Health’s Overdose Prevention Plan, by 2025.

This ordinance requires all retail pharmacies in San Francisco to keep at least two boxes of an opioid antagonist, like naloxone, on their shelves to help reverse opioid overdoses. The goal is to improve access to life-saving medication in the community.

Ordinance amending the Health Code to require each retail pharmacy in the City to stock at least two boxes of an opioid antagonist, such as naloxone, used to reverse opioid overdoses.